Search Results - "Van Moorselaar, J.A."
-
1
A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results
Published in International journal of radiation oncology, biology, physics (01-12-2019)“…Use of stereotactic body radiation therapy (SBRT) is increasing in patients with localized prostate cancer, but concerns about early and late gastrointestinal…”
Get full text
Journal Article -
2
Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer
Published in The Journal of nuclear medicine (1978) (01-09-2020)“…Quantitative evaluation of radiolabeled prostate-specific membrane antigen (PSMA) PET scans may be used to monitor treatment response in patients with prostate…”
Get full text
Journal Article -
3
Prostate cancer incidence under androgen deprivation: A nationwide cohort study in trans women receiving hormone treatment
Published in European urology open science (Online) (01-07-2020)Get full text
Journal Article -
4
The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer
Published in European urology open science (Online) (01-01-2024)“…The association between prostate-specific antigen (PSA) level and probability of metastatic disease on prostate-specific membrane antigen (PSMA) positron…”
Get full text
Journal Article -
5
Bladder Cancer detection by urinary methylation markers GHSR/MAL: a validation study
Published in World journal of urology (16-10-2024)“…Purpose Although cystoscopy is a reliable tool for detecting bladder cancer, it poses a high burden on patients and entails high costs. This highlights the…”
Get full text
Journal Article -
6
Metastatic disease after removal of a renal cell carcinoma smaller than 3 cm in a patient with Birt-Hogg-Dubé syndrome, a case report
Published in Familial cancer (01-11-2024)Get full text
Journal Article -
7
Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry
Published in European urology focus (01-09-2018)“…Abstract Background Trials in castration-resistant prostate cancer (CRPC) treatment have shown improved outcomes, including survival. However, as trial…”
Get full text
Journal Article -
8
Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer
Published in Drugs -- real world outcomes (01-06-2022)“…Background Real-world disease models spanning multiple treatment lines can provide insight into the (cost) effectiveness of treatment sequences in clinical…”
Get full text
Journal Article -
9
2536: Long term outcomes of stereotactic MR-guided adaptive radiotherapy for prostate cancer
Published in Radiotherapy and oncology (01-05-2024)Get full text
Journal Article -
10
Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer
Published in The Journal of nuclear medicine (1978) (01-05-2016)“…Repeatable quantification is essential when using (18)F-fluoromethylcholine PET/CT to monitor treatment response in prostate cancer. It has been shown that SUV…”
Get full text
Journal Article -
11
Machine learning-based analysis of [18F]DCFPyL PET radiomics for risk stratification in primary prostate cancer
Published in European journal of nuclear medicine and molecular imaging (01-02-2021)“…Purpose Quantitative prostate-specific membrane antigen (PSMA) PET analysis may provide for non-invasive and objective risk stratification of primary prostate…”
Get full text
Journal Article -
12
-
13
Optimization and validation of 18F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer
Published in PloS one (09-11-2023)“…Introduction Radiomics extracted from prostate-specific membrane antigen (PSMA)-PET modeled with machine learning (ML) may be used for prediction of disease…”
Get full text
Journal Article -
14
A protocol for urine collection and storage prior to DNA methylation analysis
Published in PloS one (24-08-2018)“…Urine poses an attractive non-invasive means for obtaining liquid biopsies for oncological diagnostics. Especially molecular analysis on urinary DNA is a rapid…”
Get full text
Journal Article -
15
Healthy Tissue Uptake of 68Ga-Prostate-Specific Membrane Antigen, 18F-DCFPyL, 18F-Fluoromethylcholine, and 18F-Dihydrotestosterone
Published in The Journal of nuclear medicine (1978) (01-08-2019)“…PET is increasingly used for prostate cancer (PCa) diagnostics. Important PCa radiotracers include 68Ga-prostate-specific membrane antigen HBED-CC (68Ga-PSMA),…”
Get full text
Journal Article -
16
Repeatability of Quantitative 18 F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer
Published in Journal of Nuclear Medicine (01-09-2020)“…Quantitative evaluation of radiolabeled prostate-specific membrane antigen (PSMA) PET scans may be used to monitor treatment response in patients with prostate…”
Get full text
Journal Article -
17
Detection of Recurrent Prostate Cancer Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients not Meeting the Phoenix Criteria for Biochemical Recurrence After Curative Radiotherapy
Published in European urology oncology (01-10-2021)“…Biochemical recurrence of prostate cancer (PCa) after curative radiotherapy is defined as a prostate-specific antigen (PSA) rise of ≥2 ng/ml above the nadir…”
Get full text
Journal Article -
18
Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): study protocol for a randomised phase III trial
Published in BMC cancer (02-05-2022)“…More than 60% of oligo-recurrent prostate cancer (PCa) patients treated with metastasis-directed radiotherapy (MDRT) develop biochemical recurrence within…”
Get full text
Journal Article -
19
Renal cancer and pneumothorax risk in Birt–Hogg–Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families
Published in British journal of cancer (06-12-2011)“…Background: Birt–Hogg–Dubé (BHD) syndrome is an autosomal dominant condition caused by germline FLCN mutations, and characterised by fibrofolliculomas,…”
Get full text
Journal Article -
20
The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer
Published in BJU international (01-02-2023)“…Objectives To investigate the role of specialised genitourinary multidisciplinary team meetings (MDTMs) in decision‐making and identify factors that influence…”
Get full text
Journal Article